RHI Magnesita N.V.
RHIM · Main Market · Chemicals · mcap £1,360m · 2925.0p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 18 Aug 26 | Board change | Board Changes – CEO Succession
Stefan Borgas steps down as CEO on 31 October 2026; Gustavo Franco appointed successor effective 1 November 2026. |
−2.6% |
| 31 Jul 26 | Results | 2026 Half Year Results | −2.1% |
| 31 Jul 26 | Results | 2026 Half Year Results
H1 2026 adjusted EBITA grew 42% on constant currency despite soft demand; FY guidance confirmed at €400m. |
−2.1% |
| 29 Apr 26 | Trading update | Q1 Trading Update
Q1 adjusted EBITA rose 15% year-on-year despite slightly weaker global demand; full-year guidance of €435m reconfirmed. |
−2.2% |
| 02 Mar 26 | Results | Annual Report
RHI Magnesita announces that it has today published the Annual Report and Accounts for the year ended 31 December 2025 (the "2025 Annual Report"). |
−15.5% |
| 02 Mar 26 | Results | 2025 Full Year Results
FY25 revenue €3,366m down 3%, Adjusted EBITA €373m with strong H2 recovery; 2026 guidance €435m (constant currency). |
−15.5% |
| 10 Dec 25 | Board change | Directorate Change
Karin Garcia concluded her four-year term as Employee Representative Director. |
+0.8% |
| 10 Nov 25 | Trading update | Trading Update
Four-month Adjusted EBITA €136m at 12.7% margin; steel demand weak but full-year guidance maintained. |
+16.9% |
| 07 Nov 25 | Board change | Directorate Change
Employee Representative Director appointed effective 1 January 2026, replacing Michael Schwarz. |
−1.8% |
| 03 Nov 25 | Board change | Directorate Change
RHI Magnesita announces that Dr Martin Kowatsch has been re-appointed as an Employee Representative Director of the Board by the Austrian Works Council, with effect from 1 November 2025, for a four-year term in accordanc |
−0.2% |
Company filings. Not investment advice.